Drug intelligence / Profile preview

MG ZEST 60

Development stage: Unknown
Lead developer: ADDUCO RBS
Administration: Oral

Overview

MG ZEST 60 is a nutraceutical product developed by ADDUCO RBS, specifically formulated to address magnesium deficiency. As a magnesium supplement, it functions by replenishing elemental magnesium levels in the body, which is essential for numerous physiological processes including muscle and nerve function, blood glucose control, and bone health. The product is currently approved and marketed as a dietary supplement.

Brand names: MG ZEST 60
Other names: MG ZEST

Targets

CaV (Voltage-gated calcium channel protein complex)NMDAR (Glutamate receptor ionotropic, NMDA)

Beyond the preview

Go deeper on MG ZEST 60.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from study design and recruitment through results.

Trial phase
Status
Readouts

Indications & development

Explore development by indication, patient population, and geography.

Indications
Development status
Countries

Licensing & deals

Trace asset ownership, licensing agreements, and commercial partnerships.

Partners
Deal terms
Milestones

Patents & exclusivity

Explore the patent landscape and regulatory exclusivity around an asset.

Patents
Expiration dates
Exclusivity

Competitive landscape

Compare development programs by target, modality, and indication.

Competing assets
Targets
Development stage

Research & analysis

Connect source evidence and development news to your research questions.

Publications
News
Analysis

Bring the full picture into focus.

See how Gosset can support your research on MG ZEST 60.

Explore the full profile